PharmAust

Home PharmAust
Clinical-stage biotechnology company PharmAust (ASX: PAA) has reported positive results from ongoing product stability and shelf-life testing of its lead anti-cancer drug candidate monepantel in tablet form.
Author:alopah/Date:2021-07-08/Views:101